Literature DB >> 9223737

Trends in HIV-1 prevalence may not reflect trends in incidence in mature epidemics: data from the Rakai population-based cohort, Uganda.

M J Wawer1, D Serwadda, R H Gray, N K Sewankambo, C Li, F Nalugoda, T Lutalo, J K Konde-Lule.   

Abstract

OBJECTIVES: To assess whether trends in serial HIV-1 prevalence reflect trend in HIV incidence, and to decompose the effects of HIV-1 incidence, mortality, mobility and compliance on HIV-1 prevalence in a population-based cohort.
DESIGN: Two-year follow up (1990-1992) of an open cohort of all adults aged 15-59 years, resident in a sample of 31 representative community clusters in rural Rakai District, Uganda.
METHODS: A detailed household enumeration was concluded at baseline and in each subsequent year. All household residents were listed, and all deaths and in- and out-migrations that occurred in the intersurvey year wee recorded. In each year, all consenting adults were interviewed and provided a serological sample; 2591 adults aged 15-59 years were enrolled at baseline.
RESULTS: HIV prevalence among adults declined significantly 1990 and 1992 (23.4% at baseline, 21.8% in 1991, 20.9% in 1992; P < 0.05). Declining prevalence was also observed in subgroups, including young adults aged 15-24 years (from 20.6 to 16.2% over 3 years; P < 0.02), women of reproductive age (from 27.1 to 23.5%; P < 0.05), and pregnant women (from 25.4 to 20.0%; not significant), However, HIV incidence did not change significantly among all adults aged 15-59 years (2.1 +/- 0.4 per 100 person-years of observation (PYO) in 1990-1991 and 2.0 +/- 0.3 per 100 PYO in 1991-1992], nor in population subgroups. HIV-related mortality was high (13.5 per 100 PYO among the HIV-positive), removing more infected persons that were added by seroconversion. Net out-migration also removed substantial numbers of HIV-positive individuals.
CONCLUSIONS: In this mature HIV epidemic, HIV prevalence declined in the presence of stable and incidence. HIV-related mortality contributed most to the prevalence decline. Prevalence was not an adequate surrogate measure of incidence, limiting the utility or serial prevalence measures in assessing the dynamics of the HIV epidemic and in evaluating the impact of current preventive strategies.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Epidemics; Hiv Infections; Incidence; Measurement; Prevalence--changes; Research Methodology; Research Report; Uganda; Viral Diseases

Mesh:

Year:  1997        PMID: 9223737     DOI: 10.1097/00002030-199708000-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  30 in total

Review 1.  Global impact of human immunodeficiency virus and AIDS.

Authors:  H D Gayle; G L Hill
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.

Authors:  D C Des Jarlais; M Marmor; P Friedmann; S Titus; E Aviles; S Deren; L Torian; D Glebatis; C Murrill; E Monterroso; S R Friedman
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

3.  Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997.

Authors:  C Des Jarlais; T Perlis; S R Friedman; T Chapman; J Kwok; R Rockwell; D Paone; J Milliken; E Monterroso
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

Review 4.  Surveys on sexual health: recent developments and future directions.

Authors:  K Wellings; J Cleland
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

5.  Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002.

Authors:  Samantha A Conroy; Oliver Laeyendecker; Andrew D Redd; Aleisha Collinson-Streng; Xiangrong Kong; Fredrick Makumbi; Tom Lutalo; Nelson Sewankambo; Noah Kiwanuka; Ronald H Gray; Maria J Wawer; David Serwadda; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-06       Impact factor: 2.205

6.  Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda.

Authors:  Chelsea B Polis; Maria J Wawer; Noah Kiwanuka; Oliver Laeyendecker; Joseph Kagaayi; Tom Lutalo; Fred Nalugoda; Godfrey Kigozi; David Serwadda; Ronald H Gray
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

7.  Mobility among youth in Rakai, Uganda: Trends, characteristics, and associations with behavioural risk factors for HIV.

Authors:  Ashley C Schuyler; Zoe R Edelstein; Sanyukta Mathur; Joseph Sekasanvu; Fred Nalugoda; Ronald Gray; Maria J Wawer; David M Serwadda; John S Santelli
Journal:  Glob Public Health       Date:  2015-08-27

Review 8.  Measuring trends in prevalence and incidence of HIV infection in countries with generalised epidemics.

Authors:  P D Ghys; E Kufa; M V George
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

9.  Trends in antenatal HIV prevalence in urban Uganda associated with uptake of preventive sexual behaviour.

Authors:  W L Kirungi; J Musinguzi; E Madraa; N Mulumba; T Callejja; P Ghys; R Bessinger
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

Review 10.  Criteria for detecting and understanding changes in the risk of HIV infection at a national level in generalised epidemics.

Authors:  G P Garnett; S Gregson; K A Stanecki
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.